Safuanova G Sh, Nikulicheva V I, Bakirov A B
Klin Lab Diagn. 2004 Jan(1):24, 33-5.
The functional status of the immune condition was comprehensively evaluated in 145 patients with posthemorrhagic iron-deficient anemia (IDA) and in 40 virtually healthy subjects (controls) by immune-diagnosis tests, degrees 1 to 3. Cytokines (negative hemopoiesis regulators), i.e. interleukins 1 and 6 (IL-1 and IL-6), tumor necrosis factor alpha (TNF-alpha) and INF-gamma were investigated. A 3-phase immune-enzyme assay with horse-radish peroxidase as enzyme indicator and the "Protein Contour" test-system were made use of. Impairments of the non-specific, cellular and humoral immunities were found in IDA patients; excessive concentrations of IL-1, IL-6 and TNF-alpha were observed in the same group of patients, which can explain some of the intercellular interaction mechanisms and which can be related with a negative impact exerted by interleukins on erythropoiesis in the discussed pathology. Decreasing concentrations of IL-1, IL-6, TNF-alpha and INF-gamma in IDA patients due to an adequate therapy by iron-containing drugs is a positive phenomenon in recovering the functional status of the immune system; it denotes that the maturation of hemoglobin-containing erythron variations and the secondary immune insufficiency are reviving.
通过1至3级免疫诊断测试,对145例出血后缺铁性贫血(IDA)患者和40名健康对照者的免疫状况功能状态进行了综合评估。研究了细胞因子(负性造血调节因子),即白细胞介素1和6(IL-1和IL-6)、肿瘤坏死因子α(TNF-α)和INF-γ。采用以辣根过氧化物酶为酶指示剂的三相免疫酶测定法和“蛋白质轮廓”测试系统。在IDA患者中发现非特异性、细胞免疫和体液免疫受损;在同一组患者中观察到IL-1、IL-6和TNF-α浓度过高,这可以解释一些细胞间相互作用机制,并且可能与白细胞介素对所讨论病理中红细胞生成的负面影响有关。由于使用含铁药物进行适当治疗,IDA患者中IL-1、IL-6、TNF-α和INF-γ浓度降低,这是免疫系统功能状态恢复中的一个积极现象;这表明含血红蛋白的红系变异的成熟和继发性免疫功能不全正在恢复。